Fluorescent xylitol carbon dots: A potent antimicrobial agent and drug carrier.
Vishal AhujaSomesh BanerjeePartha RoyArvind Kumar BhattPublished in: Biotechnology and applied biochemistry (2021)
Biomolecular carbon dots (CDs) have immense potential for various industries due to exceptional bioactivity, biocompatibility, low toxicity, and biodegradability. In the present work xylitol (Xlt), a natural sweetener produced by microbial fermentation of sugarcane bagasse (71.98% conversion) has been used for CDs preparation by microwave-assisted carbonization in the presence of ethylene diamine (EDA). The resultant xylitol carbon dots (XCDs) were irregular shaped, rough with an average size of 8.88 nm and exhibiting fluorescence between 400 and 450 nm. The presence of EDA preserves the native chemical structure of Xlt even after exposure to microwaves. Purified XCDs were conjugated (AM-XCD) with ketoconazole and tetracycline for fungi and bacteria, respectively. In comparison to Xlt, XCDs have higher inhibitory potential and reduced dosage size of antimicrobials against Cryptococcus neoformans, Candida albicans, Streptococcus pyogenes, and Escherichia coli by 75%, 75%, 87.50%, and 50%, respectively. For Listeria monocytogenes and Salmonella typhi also inhibitory potential was increased by 14.68% and 21.38%. Increased efficacy advocated the improved drug delivery in the presence of XCDs. However, no inhibitory effect was recorded against DU145 (human prostate cancer) and HCT-15 (human colon adenocarcinoma) cell lines. The findings of the current work suggested the possible use of Xlt as an important antimicrobial agent besides an efficient drug carrier in healthcare.
Keyphrases
- candida albicans
- escherichia coli
- prostate cancer
- listeria monocytogenes
- endothelial cells
- quantum dots
- biofilm formation
- healthcare
- drug delivery
- photodynamic therapy
- staphylococcus aureus
- induced pluripotent stem cells
- human health
- squamous cell carcinoma
- microbial community
- pluripotent stem cells
- radical prostatectomy
- cancer therapy
- visible light
- climate change
- single molecule
- klebsiella pneumoniae
- emergency department
- locally advanced
- mass spectrometry
- adverse drug
- drug induced
- rectal cancer
- health insurance
- heavy metals
- lactic acid
- anti inflammatory
- cell cycle arrest